Advertisement
Singapore markets open in 4 hours 54 minutes
  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Bitcoin USD

    63,351.96
    +2,160.92 (+3.53%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Gold

    2,395.00
    +6.60 (+0.28%)
     
  • Crude Oil

    82.74
    +0.05 (+0.06%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     
  • Jakarta Composite Index

    7,166.81
    -7,130.84 (-49.87%)
     
  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

McKesson Issues Statement on Change Healthcare IPO

IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) offers the below statement on today’s Change Healthcare initial public offering:

Change Healthcare, Inc., a scaled healthcare information technology company, began trading on the Nasdaq Global Select Market under the trading symbol “CHNG.” McKesson holds the majority ownership stake in Change Healthcare’s operating subsidiary.

Congratulations to Change Healthcare on this significant milestone in the company’s history. For McKesson, this is an important next step in our efforts to unlock value for McKesson shareholders from our investment in the Change Healthcare business,” said Brian Tyler, chief executive officer of McKesson.

ADVERTISEMENT

McKesson expects to exit its investment in Change Healthcare in a tax-efficient manner.

About McKesson Corporation

McKesson Corporation, currently ranked 7th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.

Cautionary Statements

Statements in this press release about the potential tax-efficient distribution of McKesson’s interest in the Change Healthcare business constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Those statements involve risks and uncertainties that could cause actual results to differ materially from those contained in those statements. It is not possible to predict or identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. The company undertakes no obligation to publicly update forward-looking statements. We encourage investors to read important risk factors described in the company’s most-recent Form 10-K filed with the Securities and Exchange Commission. Risk factors include, but are not limited to: changes in the U.S. healthcare industry and regulatory environment; the performance of McKesson’s investment in the Change Healthcare business; McKesson’s ability to manage and complete the distribution to shareholders; and new or revised tax legislation or challenges to our tax positions related to any tax-efficient distribution.

Not an offer

This press release is not an offer to sell or a solicitation of an offer to buy any securities.

Contacts

Investors and Financial Media:

Holly Weiss

972-969-9174

Holly.Weiss@McKesson.com

General and Business Media:

Kristin Chasen

415-983-8974

Kristin.Chasen@McKesson.com